Skip to Page Content
Medication Packages
Collapse        Treatment Pillars: Medication and Behavior (Recorded)
CME/CE Expiration Date: 3/15/2021*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: The Obesity Medicine Association's four obesity treatment pillars are nutrition, physical activity, behavior, and medication. Treatment plans comprised of these four approaches can help patients reach their weight and health goals. During the brand new Treatment Pillars: Medication and Behavior course, delve into the pharmacological and behavioral components of clinical obesity treatment.

 


 

Accreditation:

The Obesity Medicine Association is accreditated by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

The OMA designates this enduring material internet activity for a maximum of 4.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Formats Available: On-demand
Original Presentation Date: April 04, 2018
On-Demand Release Date: Available Now

Approved Credit:
  • Obesity Medicine Association: 4.75 AMA PRA Category 1 Credit(s), 4.75 Participation Credit(s)

  • More InfoMore Info        Treatment Pillars: Medication and Behavior (Recorded)
    Collapse Current Options for Medication Management
    W. Scott Butsch, MD, MSc and Ethan Lazarus, MD, FOMA
    CME/CE Expiration Date: 04/07/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description:

    Practical Medication Management and Currently Available Options for Obesity Treatment consists of 3 presentations:

     

    • In Practical Medication Management for Obesity Treatment, Dr. Lazarus will discuss using FDA-approved anti-obesity medications as part of a patient's overall treatment for overweight/obesity.
       
    • In Obesity Medications: What Are the Current Options?, Dr. Butsch will present a comprehensive review of the currently available anti-obesity medications that may be used as part of a patient's individualized treatment plan.
       
    • Drs. Butsch and Lazarus will then come together to address attendee questions, during the spring 2016 Pharmacotherapy Panel Discussion.

     

    The sessions within Current Options for Medication Management can be purchased together as a series, or individually by session:

     

    • To purchase the entire series, click the “Add to Cart” button located directly below the pricing, and proceed to checkout.
       
    • To purchase sessions within the series, click the “Purchase Individual Sessions” option, and select the check boxes below the session(s) you would like to purchase. Once sessions are selected, an additional “Add to Cart” button will appear below the number of sessions selected, to the right of your screen, as well as at the bottom of the page. Click the “Add to Cart” button and proceed to checkout.
    Formats Available: On-demand
    Original Presentation Date: April 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 3.00 AMA PRA Category 1 Credit(s), 3.00 Participation Credit(s)

  • More InfoMore Info Current Options for Medication Management
    Collapse Fundamentals of Obesity Treatment
    CME/CE Expiration Date: 09/01/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: The Fundamentals of Obesity Treatment course is designed to introduce the concept of obesity medicine and the fundamentals to practicing health care providers. This course is ideally the first step in developing enough knowledge and awareness so that learners either begin to treat their patients affected by obesity (while pursuing additional education in this field) or can refer their patients to those who do specialize in obesity medicine. 

     

    Presentations include:

    • The Chronic Disease of Obesity
    • Assessment and Evaluation
    • Nutrition
    • Physical Activity
    • Behavior
    • Medication

     

    Supported by an educational grant from Novo Nordisk, Inc.

     free

    Formats Available: On-demand
    Original Presentation Date: August 21, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 4.50 AMA PRA Category 1 Credit(s), 4.50 Participation Credit(s)

  • More InfoMore Info Fundamentals of Obesity Treatment
    Collapse Medication Strategies for Treating Obesity
    CME/CE Expiration Date: 07/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for the specific presentations listed below.

     

    Description:

    • The "How-tos" of Pharmacotherapy: Dr. W. Allen Rader will discuss the fundamentals of currently available anti-obesity medications.
       
    • Using Generic Drugs in Treatment of Obesity: Dr. Frank Greenway will show how pharmacologic interventions for obesity treatment can be accomplished inexpensively. This presentation will discuss generic drug options, including drug combinations that have weight-loss properties. In addition, options for pharmacologic interventions in pediatric obesity will be discussed.
       
    • Pharmacotherapy (Fall 2014): Dr. Ayaz Virji will discuss mechanisms of actions, indications, contra-indications, and side effects of currently approved anti-obesity agents. A variety of drug combinations that may be used for obesity treatment will also be reviewed.
       
    • Mechanisms and Effectiveness of Obesity Medications: Dr. Daniel Bessesen will review the current guidelines for treatment of obesity, as well as describe the mechanisms of action, effectiveness, and side effects of currently available FDA approved anti-obesity medications. He will also review the factors to consider when tailoring weight-loss pharmacotherapy to the unique needs of each patient.
       
    • Exercise with and without Metformin: Exercise is a potent stimulator of glucose uptake, independent of insulin, and it also improves insulin resistance in people with diabetes. Metformin is also used to treat insulin resistance. In this lecture, Dr. Barry Braun will provide information on the independent and combined effects of exercise and metformin on insulin resistance, blood glucose control, and risk for type 2 diabetes.
       
    • The Long-term Use of Anorectic Medications: Dr. Timothy Garvey will discuss the role of anorectic medications in long-term treatment, existing evidence for their long-term safety, long-term disease improvement or remission, and prevention of disease relapse.
       
    • Using Pharmacotherapy as a Treatment after Weight-loss Surgery: Dr. Thomas Clark will discuss the benefits of prescribing a weight-management medication to a patient who has undergone a surgical weight-loss procedure. He will explain how medication can help post-operative patients maintain their weight loss.
       
    • How Anti-obesity Medications Help with Weight-loss Maintenance: Dr. Louis Aronne will explore and review the complex physiology of maintenance in weight loss, the role of medication in weight management, as well as the approved anti-obesity medications, including review mechanism(s) of action and the current evidence.
       
    • New Anorectic Drugs in the Pipeline: Dr. Frank Greenway will familiarize learners with the current anorectic medications in late-stage obesity trials. Learn about the drugs and drug combinations currently in obesity research trials and become aware of future medications and therapeutic targets for obesity drugs.
       
    • Optimizing Obesity Treatment Using Drug Combinations: Dr. Louis Aronne will discuss combination drugs for the treatment of obesity that are currently approved by the U.S. Food and Drug Administration (FDA) as well as those currently undergoing clinical investigation. Learn how to optimize obesity treatment by combining drugs currently available.
       
    • Pharmacotherapy Panel Discussion (Spring 2015): Drs. Louis Aronne and Frank Greenway will deliberate about the use of pharmacotherapy as a method for obesity treatment and address questions learners may have.
       
    • Practical Medication Management for Obesity Treatment: Dr. Ethan Lazarus will discuss using FDA-approved anti-obesity medications as part of a patient's overall treatment for overweight/obesity.
       
    • Obesity Medications: What Are the Current Options?: Dr. W. Scott Butsch will present a comprehensive review of the currently available anti-obesity medications that may be used as part of a patient's individualized treatment plan.
       
    • Pharmacotherapy Panel Discussion (Spring 2016): Drs. W. Scott Butsch and Ethan Lazarus will come together to address attendee questions on using anti-obesity medications.

     

    The sessions within Medication Strategies for Treating Obesity can be purchased together as a series, or individually by session:

     

    • To purchase the entire series, click the “Add to Cart” button located directly below the pricing, and proceed to checkout.
       
    • To purchase sessions within the series, click the “Purchase Individual Sessions” option, and select the check boxes below the session(s) you would like to purchase. Once sessions are selected, an additional “Add to Cart” button will appear below the number of sessions selected, to the right of your screen, as well as at the bottom of the page. Click the “Add to Cart” button and proceed to checkout.

     

     

    Accreditation:


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 13.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Formats Available: On-demand
    Original Presentation Date: July 01, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 13.25 AMA PRA Category 1 Credit(s), 13.25 Participation Credit(s)

  • More InfoMore Info Medication Strategies for Treating Obesity
    Collapse Update on Pharmacologic Treatment Options
    Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, Dipl. ABOM
    CME/CE Expiration Date: 9/01/2021*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: 

    Medications for Obesity-related Diseases: Become more comfortable incorporating medications for obesity-related diseases into treatment. Dr. Harold Bays will describe conditions related to obesity for which there are therapeutic options and delve into the prescribing details for some of these medications.

     

    What's in the Pipeline for Anti-obesity Medications?: Dr. Bays provides an understanding of the anti-obesity agents in development. 

     


     

    Accreditation:

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Formats Available: On demand
    Original Presentation Date: September 29, 2018
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.75 AMA PRA Category 1 Credit(s), 1.75 Participation Credit(s)

  • More InfoMore Info Update on Pharmacologic Treatment Options
    Collapse What Every Health Care Professional Needs to Know to Treat Obesity v. 2.0
    CME/CE Expiration Date: 1/31/2020*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: The What Every Health Care Professional Needs to Know to Treat Obesity v. 2.0 provides an overview of the essential components for the treatment of the disease of obesity regarding nutrition, behavior, pharmacotherapy, and assessment and evaluation.

     


     

    Accreditation:

    The Obesity Medicine Association is accreditated by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 10.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

     

    Formats Available: On-demand
    Original Presentation Date: March 30, 2018

    Approved Credit:
  • Obesity Medicine Association: 10.00 AMA PRA Category 1 Credit(s), 10.00 Participation Credit(s)

  • More InfoMore Info What Every Health Care Professional Needs to Know to Treat Obesity v. 2.0
    Medication Individual Lectures
    Collapse An Obesity Medicine Approach to Managing Diabetes and Weight-related Complications
    Jeff Sicat, MD, FACE, FOMA, Dipl. ABOM
    CME/CE Expiration Date: 9/01/2021*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Sicat describes the medications that may cause weight gain or weight loss in patients with obesity and how weight loss may require adjustments in therapy for diabetes, lipids, hypertension, and sleep apnea.

     


     

    Accreditation:

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Formats Available: On demand
    Original Presentation Date: September 29, 2018
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info An Obesity Medicine Approach to Managing Diabetes and Weight-related Complications
    Collapse Current Concepts in Obesity Medicine
    Ethan Lazarus, MD, FOMA, Dipl. ABOM
    CME/CE Expiration Date: *06/01/2020
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Ethan Lazarus is a nationally recognized expert in obesity treatment and is a diplomate of the American Board of Obesity Medicine (ABOM). In this presentation, one will learn how to perform an assessment and gain understanding in the different treatment approaches of nutrition, behavior, physical activity, pharmacotherapy, and surgery. 

    Formats Available: On-demand
    Original Presentation Date: June 12, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.50 AMA PRA Category 1 Credit(s), 1.50 Participation Credit(s)

  • More InfoMore Info Current Concepts in Obesity Medicine
    Collapse Medication-induced Weight Gain
    Christopher Still, DO, FACN, FACP, FTOS, Dipl. ABOM
    CME/CE Expiration Date: *04/15/2020
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Still will discuss how to identify the underlying factor of medication-induced weight gain.


    Objectives:

    • Implement new treatment paradigm treating "weight first" rather than co-morbidity centric
    • Identify medication that promote weight gain and inhibits weight loss
    • Employ a shared decision making process with patients with regard to prescribing and altering medications

    Originally Recorded: Recorded on 4/21/2017

    Formats Available: On-demand
    Original Presentation Date: April 21, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info Medication-induced Weight Gain
    Collapse Obesity Medications: What Are the Current Options?
    W. Scott Butsch, MD, MSc
    CME/CE Expiration Date: 04/07/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. 


    Description:
    In Obesity Medications: What Are the Current Options?, Dr. Butsch will present a comprehensive review of the currently available anti-obesity medications that may be used as part of a patient's individualized treatment plan.

    Formats Available: On-demand
    Original Presentation Date: April 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info Obesity Medications: What Are the Current Options?
    Collapse Pediatric Obesity Pharmacotherapy
    Gitanjali Srivastava, MD, FACP, FAAP, Dipl. ABOM
    CME/CE Expiration Date: *04/15/2020
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Srivastava presentation will recognize appropriate application of available obesity pharmacotherapy in children and becoming familiar with those anti-obesity medications. 

     


    Objectives:

    • Understand that several different types of obesity exist and identifying those patient phenotypes help guide treatment algorithms
    • Become familiar with some of the anti-obesity medications prescribed in children with severe obesity or those who have failed structured lifestyle intervention
    • Begin to recognize appropriate application of available obesity pharmacotherapy in children

    Originally Recorded: Recorded on 4/21/2017

    Formats Available: On-demand
    Original Presentation Date: April 21, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info Pediatric Obesity Pharmacotherapy
    Collapse Pharmacotherapy
    W. Scott Butsch, MD, MSc, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Butsch discusses current FDA-approved and off-label anti-obesity medications along with their efficacy, indications, contraindications, and safety.

    Formats Available: On-demand
    Original Presentation Date: October 14, 2016

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info Pharmacotherapy
    Collapse Practical Medication Management for Obesity Treatment
    Ethan Lazarus, MD, FOMA
    CME/CE Expiration Date: 04/07/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. 


    Description:
    In Practical Medication Management for Obesity Treatment, Dr. Lazarus will discuss using FDA-approved anti-obesity medications as part of a patient's overall treatment for overweight/obesity.

    Formats Available: On-demand
    Original Presentation Date: April 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s), 1 Participation Credit(s)

  • More InfoMore Info Practical Medication Management for Obesity Treatment
    Collapse The Obesity Algorithm Overview and Application
    Harold Bays, MD, FTOS, FACC, FACE, FNLA, FOMA, Dipl. ABOM; Angela Fitch, MD, FACP, FOMA, Dipl. ABOM
    CME/CE Expiration Date: *04/15/2020
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Highlights of the latest updates to the Obesity Algorithm® which is a clinical resource designed to help health care professionals both understand the complexity of the disease of obesity and implement effective, evidence-based treatment strategies with patients will be discussed along with clinical applications


    Objectives:

    • Provide overview of the 2017 Obesity Algorithm
    • Discuss sentinel updates
    • Discuss illustrative examples of clinical applications
    • Describe how updates, authors, algorithm, obesity definition, people first language, office environment, genetics, cancer, obesity paradox, body composition, and energy expenditure all apply to the clinical management of patients with obesity
    • Describe concomitant medications, nutrition, transfats, diet patterns, physical exercise, motivational interviews, behavior therapy, technologies, GI hormones, newer bariatric technologies, micronutrients, minerals/trace elements, and microbiome apply to the clinical management of patients with obesity
    • Apply diverse treatment strategies to patients with various obesity phenotypes
    • Manage secondary causes of obesity
    • Identify concomitant medication issues and individualizing treatment accordingly
    • Describe nutrition, physical activity and psychological interventions for treating obesity

    Originally Recorded: Recorded on 4/20/2017

    Formats Available: On-demand
    Original Presentation Date: April 20, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 2.50 AMA PRA Category 1 Credit(s), 2.50 Participation Credit(s)

  • More InfoMore Info The Obesity Algorithm Overview and Application
    Collapse The Patient Care Continuum
    Jennifer Seger, MD, FOMA, Dipl. ABOM; Michael Seger, MD, FACS; Chris Sander, RCIS
    CME/CE Expiration Date: 9/01/2020*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Drs. Seger along with patient Chris Sander will discuss the challenges associated with obesity care and how those challenges impact patient care.

    Formats Available: On-demand
    Original Presentation Date: September 17, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.75 AMA PRA Category 1 Credit(s), 1.75 Participation Credit(s)

  • More InfoMore Info The Patient Care Continuum